Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. - Wikidata - awgldk - TriplyDB

Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts.

Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts.

http://www.wikidata.org/entity/Q34358060

about

Cytokine-Induced Modulation of Colorectal Cancer Host responses in tissue repair and fibrosis MFG-E8 regulates angiogenesis in cutaneous wound healing Unique temporal and spatial expression patterns of IL-33 in ovaries during ovulation and estrous cycle are associated with ovarian tissue homeostasis Inflammatory bowel disease in pediatric and adolescent patients: a biomolecular and histopathological review Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features.Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease.Pathogenic mouse hepatitis virus or poly(I:C) induce IL-33 in hepatocytes in murine models of hepatitis IL-33 activates tumor stroma to promote intestinal polyposis.Rhinoviral stimuli, epithelial factors and ATP signalling contribute to bronchial smooth muscle production of IL-33 Eosinophils and IL-33 Perpetuate Chronic Inflammation and Fibrosis in a Pediatric Population with Stricturing Crohn's Ileitis.Interleukin-33 ameliorates experimental colitis through promoting Th2/Foxp3⁺ regulatory T-cell responses in mice.Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis.Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis.Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.Inducible IL-33 expression by mast cells is regulated by a calcium-dependent pathway.The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice.Implications for Interleukin-33 in solid organ transplantation The role of IL-33 in gut mucosal inflammation.Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease.Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis.Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice.IFN-γ directly controls IL-33 protein level through a STAT1- and LMP2-dependent mechanism.Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations.Interleukin-33 biology with potential insights into human diseases.A role for interleukin-33 in T(H)2-polarized intestinal inflammation?Role of IL-33 in inflammation and disease.Microvascular remodeling and wound healing: a role for pericytes.Resident mesenchymal cells and fibrosis.Intestinal stromal cells in mucosal immunity and homeostasis.Emerging role of interleukin-33 in autoimmune diseases.Interleukin-33 and inflammatory bowel diseases: lessons from human studies Cellular and Molecular Mediators of Intestinal Fibrosis.The potential role of IL-33/ST2 signaling in fibrotic diseases.Interleukin 33 is a guardian of barriers and a local alarmin.Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy.Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications.Interleukin-33 promotes inflammatory cytokine production in chronic airway inflammation.Interleukin-33 in health and disease.Stromal and immune cells in gut fibrosis: the myofibroblast and the scarface.

P2860

Q26752374-911290BD-EB00-43B7-94C8-EBB71AE160DA Q26852800-C6D2DA27-DAA1-4F10-9EB0-A2BA054E419F Q33826601-8566141D-FC90-4CA6-9BA5-A86C31C315B8 Q33855694-23F1D09D-51F9-4693-9B4D-59BDDA4398A5 Q34036608-78E968EE-C02C-4BC3-9C23-4388F0AE6273 Q34389943-DED9F1EE-8261-43F4-B7A5-B50A1AF8F638 Q34698326-7DC94C3A-5429-4BB5-962D-5CECA2A0B7F2 Q34994590-1B8BBC8B-32D6-4811-BA2E-D7628A954678 Q35616286-60926E8A-1569-48C6-AE32-8651A2502574 Q35759343-07C1D926-FB93-448C-A14B-BEB76EAB0CE8 Q36053010-CA2D2626-143C-4283-A3FF-E2DD81B98B67 Q36130948-D64518B7-4432-40EF-8C77-7747A68C816E Q36444778-760AA5D7-CF23-4245-A4A4-9E9A04702D5D Q36511515-A88C13E7-1CF2-4C37-AFAC-241ABEAE2A84 Q36511796-4FB1FDE2-9E4C-41F5-8C60-0D3B75154629 Q36522848-38DEB408-BEF8-4CE0-954A-577726225BE2 Q36597522-683F867F-6B70-4207-BA97-5B28D458354C Q36807908-9051ABD5-3785-4F31-8060-EF74D5432CF6 Q36914110-BB00CA2F-1A53-4996-965A-1EBB3773D278 Q36994761-709BAEA0-BC85-40D2-8E2D-7F81522B0A9B Q37304335-7FDD8BE7-065B-4A2C-B8E6-40E36369B735 Q37345931-A166AB5F-6C8D-4CA7-98A2-0EF2744B800B Q37727601-EEC023EE-C33F-4B55-BABB-59A3E44D3A2F Q37863515-C1668742-878D-4C0E-BCFB-9CF20782349C Q37868927-E24B05D7-30C7-4286-A12E-D35052281189 Q37879908-59AB6E77-CE4F-4CC2-9CC0-2B97A6776173 Q37922810-72A55426-5DBF-4739-8A0B-111DFF8A27BF Q38023082-D5FDAA6C-986C-442C-A860-C8D55FA3DDD0 Q38065650-4C07154E-D226-482A-9FB1-7971B4A7A8F9 Q38067055-E23D9E21-9454-462A-A346-667C2B7AA569 Q38151715-9F9F500B-B452-4CEB-A857-FE9ED830B58D Q38202097-E5290483-EECB-43D2-A48C-B8B5499791E2 Q38259227-D04B54B3-5FF5-40CF-9E2B-EBCF425615EA Q38424483-142CF7EF-7B54-4F3E-B55F-F6D0667A737C Q38702558-F80720B4-6A06-4ACC-8E90-CA8F1A290F3E Q38753216-40CC4DCF-7F8D-4522-B681-8247074B3E8A Q38756562-E729CF2E-32CB-450B-9417-C3586C96ADB6 Q38855027-A49824E8-B14F-4D4F-AF43-05DFC05D9C6B Q38957840-7F5F9F24-50EA-43CD-8A64-E5B513F8FA18 Q39401444-F87BDD80-79AC-4B22-B073-6DBC6E022889

P2860

Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts.

http://www.wikidata.org/entity/Q34358060

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Inflammatory bowel disease-ass ...... ion-associated myofibroblasts.

@ast

Inflammatory bowel disease-ass ...... ion-associated myofibroblasts.

@en

Inflammatory bowel disease-ass ...... ion-associated myofibroblasts.

@nl

type

label

Inflammatory bowel disease-ass ...... ion-associated myofibroblasts.

@ast

Inflammatory bowel disease-ass ...... ion-associated myofibroblasts.

@en

Inflammatory bowel disease-ass ...... ion-associated myofibroblasts.

@nl

prefLabel

Inflammatory bowel disease-ass ...... ion-associated myofibroblasts.

@ast

Inflammatory bowel disease-ass ...... ion-associated myofibroblasts.

@en

Inflammatory bowel disease-ass ...... ion-associated myofibroblasts.

@nl

P1433

Q34358060-FB277784-5036-4D0D-B4A9-5D390D4347E9

P1476

Q34358060-A899AD5B-0133-4383-9ED1-DADA55ED3015

P2093

Q34358060-571906BA-59E9-49B4-8756-805A8E07434B

Q34358060-70492348-6B4C-4D3A-AB68-AC506E6D15CC

Q34358060-7934A914-8528-4D41-A7F4-A8044DFFDCD6

Q34358060-7EC1DC81-1549-4D09-BA1C-4242432066CA

Q34358060-8A15A9A9-358F-43A6-8134-5024430E888B

Q34358060-A47BA3C8-E261-4F1A-9118-A5C2330D39A1

Q34358060-E6D8BE4A-5C47-4E17-8ED8-177297CBADF4

Q34358060-E9BE1885-AF08-485F-9F6D-50B8F025A167

Q34358060-F5CB222F-21E0-4764-B3FD-DEF0F3877721

Q34358060-FF3C168D-0846-4AB3-A67F-D121F07068F5

P2860

Q34358060-025A389C-25A6-43EA-BAD7-E529EA4F3ADE

Q34358060-15ED4E2B-2970-4107-B5C4-017059063461

Q34358060-1D041C4A-4CB8-47B0-8139-49CD2A5C1E7E

Q34358060-206F7F97-AA45-41C2-B060-FB1E128FDC5D

Q34358060-20FD3EAF-9B57-4828-BE61-00DF0EA21F1C

Q34358060-225E87D5-559C-4B15-99C4-7A92646C12D7

Q34358060-22A9D4AC-16DF-4AFD-9954-0EF2DEC32D91

Q34358060-27950D4D-E749-4A76-AABC-9F9BBAB9662D

Q34358060-282ECE75-0313-43BB-B5A3-A7B5C7E826F3

Q34358060-2DBC8DB9-4118-4644-A8FE-B13A9A076FC0

P304

Q34358060-5AABA6F6-FEC5-414A-8923-9267E32E68CB

P31

Q34358060-8FD3DF33-1271-49FA-9945-F8B1C74ABB86

P356

Q34358060-EB9AC8D5-F371-4945-9047-5E8CC8A9AE6F

P407

Q34358060-18D674E0-B0CA-49E3-AE53-81C1ED0195D0

P433

Q34358060-555388BE-73EC-4A49-902C-814D6CB19E9D

P478

Q34358060-C4CB667D-C119-4E17-9235-012F72524488

P50

Q34358060-6D6607BA-537F-4486-8FD7-A11B52F0586C

Q34358060-F49F1C8A-31FD-409C-9B58-2D7E0B72F286

P577

Q34358060-FCE1B395-CA9A-491E-93C8-09609AE1BBD4

P5875

Q34358060-F0106C79-912C-41A6-B03B-125EAC9DACBA

P698

Q34358060-23A2367B-EA50-4329-982E-E436AD3CC2BD

P921

Q34358060-31C027B3-61AB-4ECB-AEFE-8FDAFBDFE081

Q34358060-B34FC259-0D6E-4C8F-8BB0-538881B64870

Q34358060-c123968c-6e70-4c4a-93ad-36f2dd80ba39

P932

Q34358060-4B43EBE6-BE42-4D12-9D66-7F7C5639EA07

P356

AJPATH.2010.100378

P1433

The American Journal of Pathology

P1476

Inflammatory bowel disease-ass ...... tion-associated myofibroblasts

@en

P2093

Axel M Küchler

http://www.w3.org/2001/XMLSchema#string

Clara Hammarström

http://www.w3.org/2001/XMLSchema#string

Dag Reidar Sørensen

http://www.w3.org/2001/XMLSchema#string

Hogne Røed Nilsen

http://www.w3.org/2001/XMLSchema#string

Johanna Balogh

http://www.w3.org/2001/XMLSchema#string

Jon Sponheim

http://www.w3.org/2001/XMLSchema#string

Monika Kasprzycka

http://www.w3.org/2001/XMLSchema#string

Morten H Vatn

http://www.w3.org/2001/XMLSchema#string

Tamara Loos

http://www.w3.org/2001/XMLSchema#string

Trine Olsen

http://www.w3.org/2001/XMLSchema#string

P2860

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling

Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket

The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1

Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis

The myofibroblast: one function, multiple origins

Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules

Analyzing real-time PCR data by the comparative C(T) method

Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease

IL-33, a potent inducer of adaptive immunity to intestinal nematodes

P304

2804-2815

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/AJPATH.2010.100378

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

177

http://www.w3.org/2001/XMLSchema#string

P50

Guttorm Haraldsen

Jürgen Pollheimer

P577

2010-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47635775

http://www.w3.org/2001/XMLSchema#string

P698

21037074

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

2993251

http://www.w3.org/2001/XMLSchema#string